Purification and characterization of a potential antifungal protein from Bacillus subtilis E1R-J against Valsa mali
- 702 Downloads
In order to identify the antagonistic substances produced by Bacillus subtilis E1R-J as candidate of biocontrol agents for controlling Apple Valsa Canker, hydrochloric acid precipitation, reverse phase chromatography, gel filtration, and ion exchange chromatography were used. The purified fraction EP-2 showed a single band in native-polyacrylamide gel electrophoresis (native-PAGE) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Fraction EP-2 was eluted from native-PAGE and showed a clear inhibition zone against V. mali 03-8. These results prove that EP-2 is one of the most important antifungal substances produced by B. subtilis E1R-J in fermentation broth. SDS-PAGE and Nano-LC–ESI–MS/MS analysis results demonstrated that EP-2 was likely an antifungal peptide (trA0A086WXP9), with a relative molecular mass of 12.44 kDa and isoelectric point of 9.94. The examination of antagonistic mechanism under SEM and TEM showed that EP-2 appeared to inhibit Valsa mali 03-8 by causing hyphal swelling, distortion, abnormality and protoplasts extravasation. Inhibition spectrum results showed that antifungal protein EP-2 had significantly inhibition on sixteen kinds of plant pathogenic fungi. The stability test results showed that protein EP-2 was stable with antifungal activity at temperatures as high as 100 °C for 30 min and in pH values ranging from 1.0 to 8.0, or incubated with each 5 mM Cu2+, Zn2+, Mg2+, or K+. However, the antifungal activity was negatively affected by Proteinase K treatment.
KeywordsEndophytic Bacillus subtilis Apple Valsa Canker (AVC) Biocontrol agents (BCAs) Antifungal substances
This study was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 201203034), Science and Technology Innovation Research of Shaanxi (No. 2011KTZB02-02-02) and the National Natural Science Foundation of China (31101476). We are grateful to Dr. Ralf T. Voegele at Universität Hohenheim, Dr. Bing Liu (Jiangxi Agricultural University) and Prof. Heinrich Buchenauer (University Hohenheim) for comments and improvement of the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- Baindara P, Mandal SM, Chawla N, Singh PK, Pinnaka AK, Korpole S (2013) Characterization of two antimicrobial peptides produced by a halo tolerant Bacillus subtilis strain SK.DU.4 isolated from a rhizosphere soil sample. AMB Express 3:2. http://www.amb-express.com/content/3/1/2
- Chen Y, Yan F, Chai YR, Liu HX, Kolter R, Losick R, Guo JH (2012) Biocontrol of tomato wilt disease by Bacillus subtilis isolates from natural environments depends on conserved genes mediating biofilm formation. Environ Microbiol 15:848–864. doi: 10.1111/j.1462-2920.2012.02860.x CrossRefGoogle Scholar
- Deng ZS, Zhao LF, Zhang WW, Ji YL, Wei GH (2009) Isolation of endophytic fungi from Ginkgo biloba L. and their antagonism on the Valsa mali Mayabe et Yamada. Acta Bot Boreali-Occident Sin 29:0608–0613 (in Chinese)Google Scholar
- Gao KX, Liu XG, Guo RF, Gao BJ, Zhu TB (2002) Mycoparasitism of Trichoderma spp. on five plant pathogenic fungi. J Shandong Agricult Univ 33:37–42 (in Chinese) Google Scholar
- Huang BQ, Huang LL, Kang ZS, Qiao HP (2009) Purification and characterization of an extracellular antifungal protein from wheat endophytic Bacillus subtilis strain E1R2j. Acta Agricult Boreali-Occident Sin 18(6):285–290Google Scholar
- Kang ZS (1995) Ultrastructure of plant pathogenic fungi. China Science and Technology Press, Beijing, pp 9–10 (in Chinese) Google Scholar
- Qiao HP, Huang LL, Kang ZS (2006) Endophytic bacteria isolated from wheat and their antifungal activities to soil-borne disease pathogens. Chin J Appl Ecol 17:690–694Google Scholar
- Slimene IB, Tabbene O, Gharbi D, Mnasri B, Schmitter JM, Urdaci MC, Limam F (2015) Isolation of a chitinolytic Bacillus licheniformis S213 strain exerting a biological control against phoma medicaginis infection. Appl Biochem Biotechnol 175:3494–3506. doi: 10.1007/s12010-015-1520-7 CrossRefGoogle Scholar
- Xie D, Peng J, Wang J, Hu J, Wang Y (1998) Purification and properties of antifungal protein X98III from Bacillus subtilis. Act Microbiol Sin 38:13–19 (in Chinese) Google Scholar
- Xin YF, Shang JJ (2005) Biocontrol trials of Chaetomium spirale ND35 against apple canker. J For Res 16:121–124. Article id:1007-662X(2005)02-0121-04Google Scholar
- Yang J, Ji JY, Kang ZS, Huang LL (2012) Optimization of fermentation conditions and purification of antifungal lipopeptide produced by Bacillus subtilis E1R-J. Act Agricult Boreal-Occident Sin 21:54–60 (in Chinese) Google Scholar
- Yang LR, Quan X, Xue BG, Goodwin PH, Lu SB, Wang JH, Wei D, Wu C (2015) Isolation and identification of Bacillus subtilis strain YB-05 and its antifungal substances showing antagonism against Gaeumannomyces graminis var. tritici. Biol Control 85:52–58. doi: 10.1016/j.biocontrol.2014.12.010 CrossRefGoogle Scholar
- Zhan LR, Zhang KC, Ran LX, Shi YP (2008) Isolation and identification of the antagonistic actinomycetes against Valsa mali. Hebei J For Orchard Res 23:182–186 (in Chinese) Google Scholar